Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression-Reference-Cited by-同舟云学术

Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression

Published:2020-04-06 Issue:10 Volume:204 Page:2840-2851
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Batra Lalit^ORCID,Shrestha Pradeep,Zhao Hong,Woodward Kyle B.^ORCID,Togay Alper^ORCID,Tan Min^ORCID,Grimany-Nuno Orlando,Malik Mohammad Tariq^ORCID,Coronel María M.,García Andrés J.^ORCID,Shirwan Haval^ORCID,Yolcu Esma S.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference82 articles.

1. Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

2. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates

3. Generation of Functional Human Pancreatic β Cells In Vitro

4. PD-1 and Its Ligands in Tolerance and Immunity

5. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.;Saha;J. Clin. Invest.,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation;Frontiers in Immunology;2024-09-13

2. Biomaterial-enhanced treg cell immunotherapy: A promising approach for transplant medicine and autoimmune disease treatment;Bioactive Materials;2024-07

3. Immuno-protective vesicle-crosslinked hydrogel for allogenic transplantation;Nature Communications;2024-06-18

4. Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation;The Journal of Immunology;2024-05-06

5. Moving from Insulin Substitution to the Treatment of the Underlying Autoimmune Disease in Type 1 Diabetes;Hormone Research in Paediatrics;2024-04-30